<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6746773 - Implant with coating of copolymer of vinylidenefluoride (vdf) and/or ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Implant with coating of copolymer of vinylidenefluoride (vdf) and/or tetrafluoroethylene (tfe) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures"><meta name="DC.contributor" content="Gerard H. Llanos" scheme="inventor"><meta name="DC.contributor" content="Pallassana Narayanan" scheme="inventor"><meta name="DC.contributor" content="Mark B. Roller" scheme="inventor"><meta name="DC.contributor" content="Angelo Scopelianos" scheme="inventor"><meta name="DC.contributor" content="Ethicon, Inc." scheme="assignee"><meta name="DC.date" content="2001-9-25" scheme="dateSubmitted"><meta name="DC.description" content="The present invention includes biocompatible coatings and films for use on implantable medical devices and medical devices containing such coatings and films applied to a surface thereof, which coatings/films are present on the device in an amount effective to provide an inert surface to be in contact with body tissue of a mammal upon implantation of the device in the mammal, and contain a film-forming polyfluoro copolymer containing the polymerized residue of a moiety selected from the group consisting of vinylidenefluoride and tetrafluoroethylene copolymerized with a second moiety other than the first moiety, wherein the relative amounts of the polymerized residue of the first and second moieties are effective to provide the coating and films with properties effective for use in coating implantable med devices."><meta name="DC.date" content="2004-6-8" scheme="issued"><meta name="DC.relation" content="DE:19723723:A1" scheme="references"><meta name="DC.relation" content="EP:0568310:A1" scheme="references"><meta name="DC.relation" content="EP:0633032:A1" scheme="references"><meta name="DC.relation" content="EP:0747069:A2" scheme="references"><meta name="DC.relation" content="EP:0815803:A1" scheme="references"><meta name="DC.relation" content="EP:0950386:A2" scheme="references"><meta name="DC.relation" content="EP:0968688:A1" scheme="references"><meta name="DC.relation" content="EP:1192957:A2" scheme="references"><meta name="DC.relation" content="US:3051677" scheme="references"><meta name="DC.relation" content="US:3779805" scheme="references"><meta name="DC.relation" content="US:4413359" scheme="references"><meta name="DC.relation" content="US:4423183" scheme="references"><meta name="DC.relation" content="US:4733665" scheme="references"><meta name="DC.relation" content="US:4749585" scheme="references"><meta name="DC.relation" content="US:4800882" scheme="references"><meta name="DC.relation" content="US:4871357" scheme="references"><meta name="DC.relation" content="US:4876109" scheme="references"><meta name="DC.relation" content="US:4886062" scheme="references"><meta name="DC.relation" content="US:5047020" scheme="references"><meta name="DC.relation" content="US:5053048" scheme="references"><meta name="DC.relation" content="US:5176972" scheme="references"><meta name="DC.relation" content="US:5185408" scheme="references"><meta name="DC.relation" content="US:5336518" scheme="references"><meta name="DC.relation" content="US:5342348" scheme="references"><meta name="DC.relation" content="US:5368566" scheme="references"><meta name="DC.relation" content="US:5380299" scheme="references"><meta name="DC.relation" content="US:5383853" scheme="references"><meta name="DC.relation" content="US:5383928" scheme="references"><meta name="DC.relation" content="US:5403341" scheme="references"><meta name="DC.relation" content="US:5417969" scheme="references"><meta name="DC.relation" content="US:5443458" scheme="references"><meta name="DC.relation" content="US:5447724" scheme="references"><meta name="DC.relation" content="US:5464650" scheme="references"><meta name="DC.relation" content="US:5545208" scheme="references"><meta name="DC.relation" content="US:5569463" scheme="references"><meta name="DC.relation" content="US:5575818" scheme="references"><meta name="DC.relation" content="US:5591224" scheme="references"><meta name="DC.relation" content="US:5604283" scheme="references"><meta name="DC.relation" content="US:5616608" scheme="references"><meta name="DC.relation" content="US:5632771" scheme="references"><meta name="DC.relation" content="US:5632776" scheme="references"><meta name="DC.relation" content="US:5632840" scheme="references"><meta name="DC.relation" content="US:5635201" scheme="references"><meta name="DC.relation" content="US:5665728" scheme="references"><meta name="DC.relation" content="US:5679400" scheme="references"><meta name="DC.relation" content="US:5684061" scheme="references"><meta name="DC.relation" content="US:5691311" scheme="references"><meta name="DC.relation" content="US:5697967" scheme="references"><meta name="DC.relation" content="US:5713949" scheme="references"><meta name="DC.relation" content="US:5716981" scheme="references"><meta name="DC.relation" content="US:5759205" scheme="references"><meta name="DC.relation" content="US:5776184" scheme="references"><meta name="DC.relation" content="US:5824048" scheme="references"><meta name="DC.relation" content="US:5824049" scheme="references"><meta name="DC.relation" content="US:5827587" scheme="references"><meta name="DC.relation" content="US:5865814" scheme="references"><meta name="DC.relation" content="US:5873904" scheme="references"><meta name="DC.relation" content="US:5879697" scheme="references"><meta name="DC.relation" content="US:5897911" scheme="references"><meta name="DC.relation" content="US:5922393" scheme="references"><meta name="DC.relation" content="US:5932299" scheme="references"><meta name="DC.relation" content="US:6153252" scheme="references"><meta name="DC.relation" content="WO:1998008463:A1" scheme="references"><meta name="DC.relation" content="WO:1998036784:A1" scheme="references"><meta name="DC.relation" content="WO:2000027455:A1" scheme="references"><meta name="DC.relation" content="WO:2000038754:A1" scheme="references"><meta name="DC.relation" content="WO:2001087342:A2" scheme="references"><meta name="DC.relation" content="WO:2001087376:A1" scheme="references"><meta name="DC.relation" content="WO:2002026139:A1" scheme="references"><meta name="DC.relation" content="WO:2002026281:A1" scheme="references"><meta name="citation_reference" content="Derwent Acc. No. 1999-025723, abstract of DE 19723723 A1, Dec. 3, 1998.*"><meta name="citation_reference" content="Encyclopedia of Polymer Science and Engineering, vol. 7: fluorocarbon Elastomers, p. 257-267, Mar. 1989.*"><meta name="citation_reference" content="European Search Report EP03254747 dated Dec. 3, 2003."><meta name="citation_reference" content="I. Verweire, E. Schact, B. P. Qiang, K. Wang, I. De Scheerder, &quot;Evaluation of Fluorinated Polymers As Coronary Stent Coating,&quot; Journal of Materials Science: Materials in Medicine 11. Apr. 2000."><meta name="citation_reference" content="PCT International Search Report, PCT/US01/30389, Mar. 11, 2002."><meta name="citation_patent_number" content="US:6746773"><meta name="citation_patent_application_number" content="US:09/962,292"><link rel="canonical" href="http://www.google.com/patents/US6746773"/><meta property="og:url" content="http://www.google.com/patents/US6746773"/><meta name="title" content="Patent US6746773 - Implant with coating of copolymer of vinylidenefluoride (vdf) and/or tetrafluoroethylene (tfe) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures"/><meta name="description" content="The present invention includes biocompatible coatings and films for use on implantable medical devices and medical devices containing such coatings and films applied to a surface thereof, which coatings/films are present on the device in an amount effective to provide an inert surface to be in contact with body tissue of a mammal upon implantation of the device in the mammal, and contain a film-forming polyfluoro copolymer containing the polymerized residue of a moiety selected from the group consisting of vinylidenefluoride and tetrafluoroethylene copolymerized with a second moiety other than the first moiety, wherein the relative amounts of the polymerized residue of the first and second moieties are effective to provide the coating and films with properties effective for use in coating implantable med devices."/><meta property="og:title" content="Patent US6746773 - Implant with coating of copolymer of vinylidenefluoride (vdf) and/or tetrafluoroethylene (tfe) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("uZjtU--sEZG_oQTxlYDoBw"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("JPN"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("uZjtU--sEZG_oQTxlYDoBw"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("JPN"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6746773?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6746773"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=optmBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6746773&amp;usg=AFQjCNEMMAKE0BrqNx6jlOe23gaIYHHvAg" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6746773.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6746773.pdf"></a><a class="appbar-application-grant-link" data-label="Application" href="/patents/US20020094440"></a><a class="appbar-application-grant-link" data-selected="true" data-label="Grant" href="/patents/US6746773"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6746773" style="display:none"><span itemprop="description">The present invention includes biocompatible coatings and films for use on implantable medical devices and medical devices containing such coatings and films applied to a surface thereof, which coatings/films are present on the device in an amount effective to provide an inert surface to be in contact...</span><span itemprop="url">http://www.google.com/patents/US6746773?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6746773 - Implant with coating of copolymer of vinylidenefluoride (vdf) and/or tetrafluoroethylene (tfe) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6746773 - Implant with coating of copolymer of vinylidenefluoride (vdf) and/or tetrafluoroethylene (tfe) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures" title="Patent US6746773 - Implant with coating of copolymer of vinylidenefluoride (vdf) and/or tetrafluoroethylene (tfe) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6746773 B2</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 09/962,292</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Jun 8, 2004</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Sep 25, 2001</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Sep 29, 2000</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2357881A1">CA2357881A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2357881C">CA2357881C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE60126544D1">DE60126544D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE60126544T2">DE60126544T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1192957A2">EP1192957A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1192957A3">EP1192957A3</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1192957B1">EP1192957B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1764120A1">EP1764120A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP2196226A2">EP2196226A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP2196226A3">EP2196226A3</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20020094440">US20020094440</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">09962292, </span><span class="patent-bibdata-value">962292, </span><span class="patent-bibdata-value">US 6746773 B2, </span><span class="patent-bibdata-value">US 6746773B2, </span><span class="patent-bibdata-value">US-B2-6746773, </span><span class="patent-bibdata-value">US6746773 B2, </span><span class="patent-bibdata-value">US6746773B2</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Gerard+H.+Llanos%22">Gerard H. Llanos</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Pallassana+Narayanan%22">Pallassana Narayanan</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Mark+B.+Roller%22">Mark B. Roller</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Angelo+Scopelianos%22">Angelo Scopelianos</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Ethicon,+Inc.%22">Ethicon, Inc.</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6746773.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6746773.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6746773.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (70),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (5),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (30),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (71),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (8)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6746773&usg=AFQjCNGNLImf5bVLdFAEdiAJyDaFGbkY_Q">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6746773&usg=AFQjCNHR6UwiFNYFfjq5w_jyotA78_8Tbg">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6746773B2%26KC%3DB2%26FT%3DD&usg=AFQjCNHgEqAhIN6zAHRElK4PK-iEVtv41w">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129199080" lang="EN" load-source="ifi">Implant with coating of copolymer of vinylidenefluoride (vdf) and/or tetrafluoroethylene (tfe) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures</invention-title></span><br><span class="patent-number">US 6746773 B2</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA50677974" lang="EN" load-source="patent-office"> <div class="abstract">The present invention includes biocompatible coatings and films for use on implantable medical devices and medical devices containing such coatings and films applied to a surface thereof, which coatings/films are present on the device in an amount effective to provide an inert surface to be in contact with body tissue of a mammal upon implantation of the device in the mammal, and contain a film-forming polyfluoro copolymer containing the polymerized residue of a moiety selected from the group consisting of vinylidenefluoride and tetrafluoroethylene copolymerized with a second moiety other than the first moiety, wherein the relative amounts of the polymerized residue of the first and second moieties are effective to provide the coating and films with properties effective for use in coating implantable med devices.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(4)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US6746773B2/US06746773-20040608-D00001.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US6746773B2/US06746773-20040608-D00001.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US6746773B2/US06746773-20040608-D00002.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US6746773B2/US06746773-20040608-D00002.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US6746773B2/US06746773-20040608-D00003.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US6746773B2/US06746773-20040608-D00003.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US6746773B2/US06746773-20040608-D00004.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US6746773B2/US06746773-20040608-D00004.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(5)</span></span></div><div class="patent-text"><div mxw-id="PCLM8685028" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is: </claim-statement> <div class="claim"> <div num="1" id="US-6746773-B2-CLM-00001" class="claim">
      <div class="claim-text">1. An implantable medical device: comprising,</div>
      <div class="claim-text">a biocompatible film effective to provide an inert surface to be in contact with body tissue of a mammal upon implantation of said device in said mammal, said film comprising a polyfluoro copolymer comprising from about 50 to about 92 weight percent of polymerized residue of vinylidenefluoride and about 50 to about 8 weight percent of polymerized residue of hexafluoropropylene. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" id="US-6746773-B2-CLM-00002" class="claim">
      <div class="claim-text">2. The device of <claim-ref idref="US-6746773-B2-CLM-00001">claim 1</claim-ref>, wherein said polyfluoro copolymer comprises from about 50 to about 85 weight percent of said polymerized residue of said vinylidenefluoride copolymerized with from about 50 to about 15 weight percent of said polymerized residue of said hexafluoropropylene.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" id="US-6746773-B2-CLM-00003" class="claim">
      <div class="claim-text">3. The device of <claim-ref idref="US-6746773-B2-CLM-00001">claim 1</claim-ref>, wherein said copolymer comprises from about 55 to about 65 weight percent of said polymerized residue of said vinylidenefluoride copolymerized with from about 45 to about 35 weight percent of said polymerized residue of said hexafluoropropylene.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" id="US-6746773-B2-CLM-00004" class="claim">
      <div class="claim-text">4. The implantable medical device of <claim-ref idref="US-6746773-B2-CLM-00001">claim 1</claim-ref>, wherein said film further comprises effective amounts of a therapeutic and/or pharmaceutical agent.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" id="US-6746773-B2-CLM-00005" class="claim">
      <div class="claim-text">5. The implantable device of <claim-ref idref="US-6746773-B2-CLM-00001">claim 1</claim-ref> wherein said polyfluoro copolymer is effective to provide said film with properties effective for use in coating said implantable medical device when said coated device is subjected to a maximum temperature of less than 100° C.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES54192751" lang="EN" load-source="patent-office" class="description">
    <p>This patent application is a continuation-in-part of U.S. patent application Ser. No. 09/675,882, filed on Sep. 29,2000, abandoned on Oct. 22, 2002.</p>
    <heading>FIELD OF THE INVENTION</heading> <p>The invention relates to the use of polyfluoro copolymers as coatings for implantable surgical medical devices.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p>Implantable medical devices are used in various medical procedures. Such devices include, without limitation, stents, catheters, sutures, meshes, vascular grafts, shunts and filters for removing emboli.</p>
    <p>Stents, which generally are open tubular structures, have become increasingly important in medical procedures to restore the function of body lumens. Stents now are commonly used in translumenial procedures such as angioplasty to restore adequate blood flow to the heart and other organs. However, deployment of stents may stimulate foreign body reactions thereto that result in thrombosis or restenosis.</p>
    <p>To avoid these complications, a variety of stent coatings and compositions have been proposed to reduce the incidence of these complications. The coatings may be capable themselves of reducing the stimulus the stent provides to the injured lumen wall, thus reducing the tendency towards thrombosis or restenosis. Alternately, the coating may deliver a pharmaceutical/therapeutic agent or drug to the lumen that reduces smooth muscle tissue proliferation or restenosis. The reported mechanism for delivery of the agent has been via diffusion of the agent through either the bulk polymer, or through pores that are created in the polymer structure, or by erosion of a biodegradable coating.</p>
    <p>Both bioabsorbable and biostable compositions have been reported as coatings for stents. They generally have been polymeric coatings that either encapsulate a pharmaceutical/therapeutic agent or drug, e.g. taxol, rapamycin, etc., or bind such an agent to the surface, e.g. heparin-coated stents. These coatings are applied to the stent in a number of ways, including, though not limited to, dip, spray, or spin coating processes.</p>
    <p>One class of biostable materials that has been reported as coatings for stents is polyfluoro homopolymers. Polytetrafluoroethylene (PTFE) homopolymers have been used as implants for many years. These homopolymers are not soluble in any solvent at reasonable temperatures and therefore are difficult to coat onto small medical devices while maintaining important features of the devices (e.g. slots in stents).</p>
    <p>Stents with coatings made from polyvinylideneflouride homopolymers and containing pharmaceutical/therapeutic agents or drugs for release have been suggested. However, like most crystalline polyfluoro homopolymers, they are difficult to apply as high quality films onto surfaces without subjecting them to relatively high temperatures, e.g. greater than about 125-200° C., that correspond to the melting temperature of the polymer.</p>
    <p>It would be advantageous to develop coatings for implantable medical devices that will reduce thrombosis, restenosis, or other adverse reactions, that may include, but do not require, the use of pharmaceutical or therapeutic agents or drugs to achieve such affects, and that possess physical and mechanical properties effective for use in such devices, even when such coated devices are subjected to relatively low maximum temperatures.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>The present invention includes biocompatible coatings and films for use on implantable medical devices and medical devices comprising such coatings and films applied to a surface thereof that is to be in contact with body tissue of a mammal. The biocompatible film provides an inert surface to be in contact with body tissue of a mammal upon implantation of the device in the mammal. The coating and film comprise a film-forming polyfluoro copolymer comprising the polymerized residue of a first moiety selected from the group consisting of vinylidenefluoride (VDF) and tetrafluoroethylene (TFE), and the polymerized residue of a second moiety other than said first moiety and which is copolymerized with said first moiety, thereby producing the polyflouro copolymer, said second moiety being capable of providing toughness or elastomeric properties to the polyfluoro copolymer, wherein the relative amounts of said polymerized residue of said first moiety and said polymerized residue of said second moiety are effective to provide the coating and film produced therefrom with properties effective for use in coating implantable medical devices.</p>
    <heading>BRIEF DESCRIPTION OF THE FIGURES</heading> <p>FIG. 1 indicates the fraction of drug released as a function of time from coatings of the present invention over which no topcoat has been disposed.</p>
    <p>FIG. 2 indicates the fraction of drug released as a function of time from coatings of the present invention including a topcoat disposed thereon.</p>
    <p>FIG. 3 indicates the fraction of drug released as a function of time from coatings of the present invention over which no topcoat has been disposed.</p>
    <p>FIG. 4 indicates in vivo stent release kinetics of rapamycin from poly(VDF/HFP).</p>
    <heading>DETAILED DESCRIPTION OF THE INVENTION</heading> <p>The present invention provides polymeric coatings comprising a polyfluoro copolymer and implantable medical devices, e.g. stents, coated with a film of the polyfluoro polymeric coating in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures. As used herein, polyfluoro copolymers means those copolymers comprising the polymerized residue of a first moiety selected from the group consisting of vinylidenefluoride and tetrafluoroethylene, the polymerized residue of a second moiety other than the first moiety and which is copolymerized with the first moiety to produce the polyfluoro copolymer, said second moiety being capable of providing toughness or elastomeric properties to the polyfluoro copolymer, wherein the relative amounts of the polymerized residue of the first moiety and the polymerized residue of the second moiety are effective to provide coatings and films made from such polyfluoro copolymers with properties effective for use in coating implantable medical devices.</p>
    <p>In certain embodiments, the invention provides an inert, low surface energy coating for medical devices that are implanted into the body of a mammal and later retrieved therefrom. The low surface energy coating makes wetting of the device surface and protein deposition thereon difficult, which could prolong the time for encapsulation in the body, after which time the device could be removed easily.</p>
    <p>In certain embodiments of the invention, although not necessary, the coatings may comprise pharmaceutical or therapeutic agents in amounts effective for achieving desired purposes, e.g. for reducing thrombosis or restenosis, and stents coated with such coatings may provide sustained release of the agents. Films prepared from certain polyfluoro copolymer coatings of the present invention provide the physical and mechanical properties required of conventional coated medical devices, even where maximum temperatures to which the device, coatings and films are exposed are limited to relatively low temperatures, e.g. less than about 100° C., preferably at about ambient temperatures. This is particularly important when using the coating/film to deliver pharmaceutical/therapeutic agent or drugs that are heat sensitive, or when applying the coating onto temperature-sensitive devices such as, but not limited to, catheters. When maximum exposure temperature is not an issue, e.g. where heat-stable agents such as itraconazole are incorporated into the coatings, higher melting thermoplastic polyfluoro copolymers may be used and, if very high elongation and adhesion is required, elastomers may be used. If desired or required, the polyfluoro elastomers may be crosslinked by standard methods described in, e.g. <i>Modern Fluoropolymers</i>, J. Shires editor, John Wiley &amp; Sons, New York, 1997, pp. 77-87.</p>
    <p>The present invention comprises polyfluoro copolymers that provide improved biocompatible coatings for medical devices. These coatings provide inert surfaces to be in contact with body tissue of a mammal, e.g. a human, sufficient to reduce thrombosis, or restenosis, or other undesirable reactions. While most reported coatings made from polyfluoro homopolymers are insoluble and/or require high heat, e.g. greater than about 125° C., to obtain films with adequate physical and mechanical properties for use on implantable devices, e.g. stents, or are not particularly tough or elastomeric, films prepared from the polyfluoro copolymer coatings of the present invention provide adequate adhesion, toughness or elasticity, and resistance to cracking when formed on medical devices claimed herein. In certain embodiments, this is the case even where the coated devices are subjected to relatively low maximum temperatures, e.g. less than about 100° C., preferably less than about 65° C., and more preferably about 60° C. or less. In such cases, preferred polyfluoro copolymers may comprise the polymerized residue of from about 65 to about 55 weight percent polymerized residue of the first moiety, e.g. VDF, and from about 35 to about 45 weight percent polymerized residue of the second moiety, e.g. hexafluoropropylene. In certain embodiments, such polyfluoro copolymers will be crystalline, although amorphous copolymers of similar composition also are employed.</p>
    <p>The polyfluoro copolymers used for coatings according to the present invention must be film-forming polymers that have molecular weight high enough so as not to be waxy or tacky. The polymers and films formed therefrom must adhere to the stent and not be readily deformable after deposition on the stent as to be able to be displaced by hemodynamic stresses. The polymer molecular weight must be high enough to provide sufficient toughness so that films comprising the polymers will not be rubbed off during handling or deployment of the stent. In certain embodiments the coating will not crack where expansion of the stent or other medical devices, such as vena cava filters, occurs. The flow point of the polymer used in the present invention should be above 40° C., preferably above about 45° C., more preferably above 50° C. and most preferably above 55° C.</p>
    <p>Coatings of the present invention comprise polyfluoro copolymers, as defined hereinabove. The second moiety copolymerized with the first moiety to prepare the polyfluoro copolymer may be selected from those biocompatible monomers that would provide biocompatible polymers acceptable for implantation in a mammal, while maintaining sufficient elastomeric film properties for use on medical devices claimed herein. Such monomers include, without limitation, hexafluoropropylene (HFP), tetrafluoroethylene (TFE), VDF, 1-hydropentafluoropropylene, perfluoro(methyl vinyl ether), chlorotrifluoroethylene (CTFE), pentafluoropropene, trifluoroethylene, hexafluoroacetone and hexafluoroisobutylene.</p>
    <p>Polyfluoro copolymers used in the present invention typically comprise vinylidinefluoride copolymerized with HFP, in the weight ratio of from about 50 to about 92 weight percent vinylidinefluoride to about 50 to about 8 weight percent HFP. Preferably, polyfluoro copolymers used in the present invention comprise from about 50 to about 85 weight percent VDF copolymerized with from about 50 to about 15 weight percent HFP. More preferably, the polyfluoro copolymers will comprise from about 55 to about 70 weight percent VDF copolymerized with from about 45 to about 30 weight percent HFP. Even more preferably, polyfluoro copolymers comprise from about 55 to about 65 weight percent VDF copolymerized with from about 45 to about 35 weight percent HFP. Such polyfluoro copolymers are soluble, in varying degrees, in solvents such as dimethylacetamide (DMAc), tetrahydrofuran, dimethyl formamide, dimethyl sulfoxide and n-methyl pyrrolidone. Some are soluble in methylethylketone (MEK), acetone, methanol and other solvents commonly used in applying coatings to conventional implantable medical devices.</p>
    <p>Conventional polyfluoro homopolymers are crystalline and difficult to apply as high quality films onto metal surfaces without exposing the coatings to relatively high temperatures that correspond to the melting temperature (Tm) of the polymer. The elevated temperature serves to provide films prepared from such PVDF homopolymer coatings that exhibit sufficient adhesion of the film to the device, while preferably maintaining sufficient flexability to resist film cracking upon expansion/contraction of the coated medical device. Certain films and coatings according to the present invention provide these same physical and mechanical properties, or essentially the same properties, even when the maximum temperatures to which the coatings and films are exposed is less than about 100° C., and preferably less than about 65° C. This is particularly important when the coatings/films comprise pharmaceutical or therapeutic agents or drugs that are heat sensitive, e.g. subject to chemical or physical degradation or other heat-induced negative affects, or when coating heat sensitive substrates of medical devices, e.g. subject to heat-induced compositional or structural degradation.</p>
    <p>Depending on the particular device upon which the coatings and films of the present invention are to be applied and the particular use/result required of the device, polyfluoro copolymers used to prepare such devices may be crystalline, semi-crystalline or amorphous.</p>
    <p>Where devices have no restrictions or limitations with respect to exposure of same to elevated temperatures, e.g. 100° C. or higher, crystalline polyfluoro copolymers may be employed. Crystalline polyfluoro copolymers tend to resist the tendency to flow under applied stress or gravity when exposed to temperatures above their glass transition (Tg) temperatures. Crystalline polyfluoro copolymers provide tougher coatings and films than their fully amorphous counterparts. In addition, crystalline polymers are more lubricious and more easily handled through crimping and transfer processes used to mount self-expanding stents, e.g. nitinol stents.</p>
    <p>Semi-crystalline and amorphous polyfluoro copolymers are advantageous where exposure to elevated temperatures is an issue, e.g. where heat-sensitive pharmaceutical or therapeutic agents are incorporated into the coatings and films, or where device design, structure and/or use preclude exposure to such elevated temperatures. Semi-crystalline polyfluoro copolymer elastomers comprising relatively high levels, e.g. from about 30 to about 45 weight percent of the second moiety, e.g. HFP, copolymerized with the first moiety, e.g. VDF, have the advantage of reduced coefficient of friction and self-blocking relative to amorphous polyfluoro copolymer elastomers. Such characteristics can be of significant value when processing, packaging and delivering medical devices coated with such polyfluoro copolymers. In addition, such polyfluoro copolymer elastomers comprising such relatively high content of the second moiety serves to control the solubility of certain agents, e.g. Sirolimus, in the polymer and therefore controls permeability of the agent through the matrix.</p>
    <p>Polyfluoro copolymers utilized in the present inventions may be prepared by various known polymerization methods. For example, high pressure, free-radical, semi-continuous emulsion polymerization techniques such as those disclosed in <i>Fluoroelastomers</i>-<i>dependence of relaxation phenomena on composition</i>, POLYMER 30, 2180, 1989, by Ajroldi, et al, may be employed to prepare amorphous polyfluoro copolymers, some of which may be elastomers. In addition, free-radical batch emulsion polymerization techniques disclosed herein may be used to obtain polymers that are semi-crystalline, even where relatively high levels of the second moiety, e.g. greater than about 19-20 mole percent (equivalent to about 36-37 weight percent), are included.</p>
    <p>One embodiment of the invention comprises stents coated with a film of a polyfluoro copolymer according to the present invention. Conventional stents are used in translumenial procedures such as angioplasty to restore adequate blood flow to the heart and other organs. They generally are cylindrical and perforated with passages that are slots, ovoid, circular or the like shape. Stents also may be composed of helically wound or serpentine wire structures in which the spaces between the wires form passages. Stents may be flat perforated structures that are subsequently rolled to form tubular or cylindrical structures that are woven, wrapped, drilled, etched or cut to form passages. Examples of stents that may be advantageously coated by polyfluoro copolymers of the present invention include, but are not limited to, stents described in U.S. Pat. Nos. 4,733,665; 4,800,882; 4,886,062, 5,514,154, and 6,190,403, the contents each of which is incorporated herein in its entirety as if set forth herein. These stents can be made of biocompatible materials, including biostable and bioabsorbable materials. Suitable biocompatible metals include, but are not limited to, stainless steel, tantalum, titanium alloys (including nitinol), and cobalt alloys (including cobalt-chromium-nickel alloys). Suitable nonmetallic biocompatible materials include, but are not limited to, polyamides, polyolefins (i.e. polypropylene, polyethylene etc.), nonabsorbable polyesters (i.e. polyethylene terephthalate), and bioabsorbable aliphatic polyesters (i.e. homopolymers and copolymers of lactic acid, glycolic acid, lactide, glycolide, para-dioxanone, trimethylene carbonate, ε-caprolactone, and blends thereof).</p>
    <p>The film-forming biocompatible polymer coatings generally are applied to the stent in order to reduce local turbulence in blood flow through the stent, as well as adverse tissue reactions. The coatings and films formed therefrom also may be used to administer a pharmaceutically active material to the site of the stent placement. Generally, the amount of polymer coating to be applied to the stent will vary depending on, among other possible parameters, the particular polyfluoro copolymer used to prepare the coating, the stent design and the desired effect of the coating. Generally, the coated stent will comprise from about 0.1 to about 15 weight percent of the coating, preferably from about 0.4 to about 10 weight percent. The polyfluoro copolymer coatings may be applied in one or more coating steps, depending on the amount of polyfluoro copolymer to be applied. Different polyfluoro copolymers may be used for different layers in the stent coating. In fact, in certain embodiments, it is highly advantageous to use a diluted first coating solution comprising a polyfluoro copolymer as a primer to promote adhesion of a subsequent polyfluoro copolymer coating layer that may contain pharmaceutically active materials. The individual coatings may be prepared from different polyfluoro copolymers.</p>
    <p>Additionally, a top coating can be applied to delay release of the pharmaceutical agent, or they could be used as the matrix for the delivery of a different pharmaceutically active material. Layering of coatings can be used to stage release of the drug or to control release of different agents placed in different layers.</p>
    <p>Blends of polyfluoro copolymers also may be used to control the release rate of different agents or to provide desirable balance of coating properties, i.e. elasticity, toughness, etc., and drug delivery characteristics, e.g. release profile. Polyfluoro copolymers with different solubilities in solvents can be used to build up different polymer layers that may be used to deliver different drugs or to control the release profile of a drug. For example, polyfluoro copolymers comprising 85.5/14.5 (wt/wt) of poly(VDF/HFP) and 60.6/39.4 (wt/wt) of poly(VDF/HFP) are both soluble in DMAc. However, only the 60.6/39.4 poly(VDF/HFP) polyfluoro copolymer is soluble in methanol.</p>
    <p>So, a first layer of the 85.5/14.5 poly(VDF/HFP) polyfluoro copolymer comprising a drug could be over-coated with a topcoat of the 60.6/39.4 poly(VDF/HFP) polyfluoro copolymer made with the methanol solvent. The top coating can be used to delay the drug deliver of the drug contained in the first layer. Alternatively, the second layer could contain a different drug to provide for sequential drug delivery. Multiple layers of different drugs could be provided by alternating layers of first one polyfluoro copolymer, then the other. As will be readily appreciated by those skilled in the art numerous layering approaches can be used to provide the desired drug delivery.</p>
    <p>The coatings can be used to deliver therapeutic and pharmaceutic agents such as, but not limited to: antiproliferative/antimitotic agents including natural products such as vinca alkaloids (i.e. vinblastine, vincristine, and vinorelbine), paclitaxel, epidipodophyllotoxins (i.e. etoposide, teniposide), antibiotics (dactinomycin (actinomycin D) daunorubicin, doxorubicin and idarubicin), anthracyclines, mitoxantrone, bleomycins, plicamycin (mithramycin) and mitomycin, enzymes (L-asparaginase which systemically metabolizes L-asparagine and deprives cells which don't have the capacity to synthesize their own asparagine); antiproliferative/antimitotic alkylating agents such as nitrogen mustards (mechlorethamine, cyclophosphamide and analogs, melphalan, chlorambucil), ethylenimines and methylmelamines (hexamethylmelamine and thiotepa), alkyl sulfonates-busulfan, nirtosoureas (carmustine (BCNU) and analogs, streptozocin), trazenes—dacarbazinine (DTIC); antiproliferative/antimitotic antimetabolites such as folic acid analogs (methotrexate), pyrimidine analogs (fluorouracil, floxuridine, and cytarabine), purine analogs and related inhibitors (mercaptopurine, thioguanine, pentostatin and 2-chlorodeoxyadenosine{cladribine}); platinum coordination complexes (cisplatin, carboplatin), procarbazine, hydroxyurea, mitotane, aminoglutethimide; hormones (i.e. estrogen); Anticoagulants (heparin, synthetic heparin salts and other inhibitors of thrombin); fibrinolytic agents (such as tissue plasminogen activator, streptokinase and urokinase), aspirin, dipyridamole, ticlopidine, clopidogrel, abciximab; antimigratory; antisecretory (breveldin); antiinflammatory: such as adrenocortical steroids (cortisol, cortisone, fludrocortisone, prednisone, prednisolone, 6α-methylprednisolone, triamcinolone, betamethasone, and dexamethasone), non-steroidal agents (salicylic acid derivatives i.e. aspirin; para-aminophenol derivatives i.e. acetominophen; Indole and indene acetic acids (indomethacin, sulindac, and etodalac), heteroaryl acetic acids (tolmetin, diclofenac, and ketorolac), arylpropionic acids (ibuprofen and derivatives), anthranilic acids (mefenamic acid, and meclofenamic acid), enolic acids (piroxicam, tenoxicam, phenylbutazone, and oxyphenthatrazone), nabumetone, gold compounds (auranofin, aurothioglucose, gold sodium thiomalate); immunosuppressives: (cyclosporine, tacrolimus (FK-506), sirolimus (rapamycin), azathioprine, mycophenolate mofetil); Angiogenic agents: vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF); nitric oxide donors; cell cycle inhibitors; mTOR inhibitors; growth factor signal transduction knase inhibitors; anti-sense oligonucleotide; prodrug molecules; and combinations thereof.</p>
    <p>Coatings may be formulated by mixing one or more therapeutic agents with the coating polyfluoro copolymers in a coating mixture. The therapeutic agent may be present as a liquid, a finely divided solid, or any other appropriate physical form. Optionally, the coating mixture may include one or more additives, e.g., nontoxic auxiliary substances such as diluents, carriers, excipients, stabilizers or the like. Other suitable additives may be formulated with the polymer and pharmaceutically active agent or compound. For example, a hydrophilic polymer may be added to a biocompatible hydrophobic coating to modify the release profile, or a hydrophobic polymer may be added to a hydrophilic coating to modify the release profile. One example would be adding a hydrophilic polymer selected from the group consisting of polyethylene oxide, polyvinyl pyrrolidone, polyethylene glycol, carboxylmethyl cellulose, and hydroxymethyl cellulose to a polyfluoro copolymer coating to modify the release profile. Appropriate relative amounts can be determined by monitoring the in vitro and/or in vivo release profiles for the therapeutic agents.</p>
    <p>The best conditions for the coating application are when the polyfluoro copolymer and pharmaceutic agent have a common solvent. This provides a wet coating that is a true solution. Less desirable, yet still usable, are coatings that contain the pharmaceutical agent as a solid dispersion in a solution of the polymer in solvent. Under the dispersion conditions, care must be taken to ensure that the particle size of the dispersed pharmaceutical powder, both the primary powder size and its aggregates and agglomerates, is small enough not to cause an irregular coating surface or to clog the slots of the stent that need to remain essentially free of coating. In cases where a dispersion is applied to the stent and the smoothness of the coating film surface requires improvement, or to be ensured that all particles of the drug are fully encapsulated in the polymer, or in cases where the release rate of the drug is to be slowed, a clear (polyfluoro copolymer only) topcoat of the same polyfluoro copolymer used to provide sustained release of the drug or another polyfluoro copolymer that further restricts the diffusion of the drug out of the coating can be applied. The topcoat can be applied by dip coating with mandrel to clear the slots, referred to herein as the dip and wipe method. This method is disclosed in U.S. Pat. No. 6,153,252, the contents of which are incorporated herein in their entirety. Other methods for applying the topcoat include spin coating and spray coating. Dip coating of the top coat can be problematic if the drug is very soluble in the coating solvent, which swells the polyfluoro copolymer, and the clear coating solution acts as a zero concentration sink and redissolves previously deposited drug. The time spent in the dip bath may need to be limited so that the drug is not extracted out into the drug-free bath. Drying should be rapid so that the previously deposited drug does not completely diffuse into the topcoat.</p>
    <p>The amount of therapeutic agent will be dependent upon the particular drug employed and medical condition being treated. Typically, the amount of drug represents about 0.001% to about 70%, more typically about 0.001% to about 60%.</p>
    <p>The quantity and type of polyfluoro copolymers employed in the coating film containing the pharmaceutic agent will vary depending on the release profile desired and the amount of drug employed. The product may contain blends of the same or different polyfluoro copolymers having different molecular weights to provide the desired release profile or consistency to a given formulation.</p>
    <p>Polyfluoro copolymers may release dispersed drug by diffusion. This can result in prolonged delivery (over, say 1 to 2,000 hours, preferably 2 to 800 hours) of effective amounts (say, 0.001 μg/cm<sup>2</sup>-min to 100 μg/cm<sup>2</sup>-min) of the drug. The dosage can be tailored to the subject being treated, the severity of the affliction, the judgment of the prescribing physician, and the like. Individual formulations of drugs and polyfluoro copolymers may be tested in appropriate in vitro and in vivo models to achieve the desired drug release profiles. For example, a drug could be formulated with a polyfluoro copolymer, or blend of polyfluoro copolymers, coated onto a stent and placed in an agitated or circulating fluid system, e.g. 25% ethanol in water. Samples of the circulating fluid could be taken to determine the release profile (such as by HPLC, UV analysis or use of radiotagged molecules). The release of a pharmaceutical compound from a stent coating into the interior wall of a lumen could be modeled in appropriate animal system. The drug release profile could then be monitored by appropriate means such as, by taking samples at specific times and assaying the samples for drug concentration (using HPLC to detect drug concentration). Thrombus formation can be modeled in animal models using the <sup>111 </sup>In-platelet imaging methods described by Hanson and Harker, Proc. Natl. Acad. Sci. USA 85:3184-3188 (1988). Following this or similar procedures, those skilled in the art will be able to formulate a variety of stent coating formulations.</p>
    <p>While not a requirement of the present invention, the coatings and films may be crosslinked once applied to the medical devices. Crosslinking may be affected by any of the known crosslinking mechanisms, such as chemical, heat or light. In addition, crosslinking initiators and promoters may be used where applicable and appropriate. In those embodiments utilizing crosslinked films comprising pharmaceutical agents, curing may affect the rate at which the drug diffuses from the coating. Crosslinked polyfluoro copolymers films and coatings of the present invention also may be used without drug to modify the surface of implantable medical devices.</p>
    <heading>EXAMPLES</heading> <heading>Example 1</heading> <p>A poly(VDF) homopolymer (Solef 1008 from Solvay Advanced Polymers, Houston, Tex., Tm about 175° C.) and polyfluoro copolymers of poly(VDF/HFP), 92/8 and 91/9 weight percent VDF/HFP, respectively, as determined by F<sup>19 </sup>NMR (eg: Solef 11010 and 11008, Solvay Advanced Polymers, Houston, Tex., Tm about 159° C. and 160° C., respectively) were examined as potential coatings for stents. These polymers are soluble in solvents such as, but not limited to, DMAc, N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), N-methylpyrrolidone (NMP), tetrahydrofuran (THF) and acetone. Polymer coatings were prepared by dissolving the polymers in acetone, at 5 weight percent as a primer, or by dissolving the polymer in 50/50 DMAc/acetone, at 30 weight percent as a topcoat. Coatings that were applied to the stents by dipping and dried at 60° C. in air for several hours, followed by 60° C. for 3 hours in a &lt;100 mm Hg vacuum, resulted in white foamy films. As applied, these films adhered poorly to the stent and flaked off, indicating they were too brittle. When stents coated in this manner were heated above 175° C., i.e. above the melting temperature of the polymer, a clear, adherent film was formed. Such coatings require high temperatures, e.g. above the melting temperature of the polymer, to achieve high quality films.</p>
    <heading>Example 2</heading> <p>A polyfluoro copolymer (Solef 21508) comprising 85.5 weight percent VDF copolymerized with 14.5 weight percent HFP, as determined by F<sup>19 </sup>NMR, was evaluated. This copolymer is less crystalline than the polyfluoro homopolymer and copolymers described in Example 1. It also has a lower melting point reported to be about 133° C. Once again, a coating comprising about 20 weight percent of the polyfluoro copolymer was applied from a polymer solution in 50/50 DMAc/MEK. After drying (in air) at 60° C. for several hours, followed by 60° C. for 3 hours in a &lt;100 mtorr Hg vacuum, clear adherent films were obtained. This eliminated the need for a high temperature heat treatment to achieve high quality films. Coatings were smoother and more adherent than those of Example 1. Some coated stents that underwent expansion show some degree of adhesion loss and “tenting” as the film pulls away from the metal. Where necessary, modification of coatings containing such copolymers may be made, e.g. by addition of plasticizers or the like to the coating compositions. Films prepared from such coatings may be used to coat stents or other medical devices, particularly where those devices are not susceptible to expansion to the degree of the stents.</p>
    <p>The coating process above was repeated, this time with a coating comprising the 85.5/14.6 (wt/wt) (VDF/HFP) and about thirty (30) weight percent of rapamycin (Wyeth-Ayerst Laboratories, Philadelphia, Pa.), based on total weight of coating solids. Clear films that would occasionally crack or peel upon expansion of the coated stents resulted. It is believed that inclusion of plasticizers and the like in the coating composition will result in coatings and films for use on stents and other medical devices that are not susceptible to such cracking and peeling.</p>
    <heading>Example 3</heading> <p>Polyfluoro copolymers of still higher HFP content then were examined. This series of polymers were not semi-crystalline, but rather are marketed as elastomers. One such copolymer is Fluorel FC-2261Q (from Dyneon, a 3M-Hoechst Enterprise, Oakdale, Minn.), a 60.6/39.4 (wt/wt) copolymer of VDF/HFP. Although this copolymer has a Tg well below room temperature (Tg about −20° C.), it is not tacky at room temperature or even at 60° C. This polymer has no detectable crystallinity when measured by Differential Scanning Calorimetry (DSC) or by wide angle X-ray diffraction. Films formed on stents as described above were non-tacky, clear, and expanded without incident when the stents were expanded.</p>
    <p>The coating process above was repeated, this time with coatings comprising the 60.6/39.4 (wt/wt) poly(VDF/HFP) and about nine (9), thirty (30) and fifty (50) weight percent of rapamycin , based on total weight of coating solids, respectively. Coatings comprising about 9 and 30 weight percent rapamycin provided white, adherent, tough films that expanded without incident on the stent. Inclusion of 50% drug, in the same manner, resulted in some loss of adhesion upon expansion.</p>
    <p>Changes in the comonomer composition of the polyfluoro copolymer also can affect the nature of the solid state coating, once dried. For example, the semi-crystalline copolymer, Solef 21508, containing 85.5% VDF polymerized with 14.5% by weight HFP forms homogeneous solutions with about 30% rapamycin (drug weight divided by total solids weight, e.g. drug plus copolymer) in DMAc and 50/50 DMAc/MEK. When the film is dried (60° C./16 hours followed by 60° C./3 hours in vacuum of 100 mm Hg) a clear coating, indicating a solid solution of the drug in the polymer, is obtained. Conversely, when an amorphous copolymer, Fluorel FC-2261Q, of poly(VDF/HFP) at 60.6/39.5 (wt/wt) forms a similar 30% solution of rapamycin in DMAc/MEK and is similarly dried, a white film, indicating phase separation of the drug and the polymer, is obtained. This second drug containing film is much slower to release the drug into an in vitro test solution of 25% ethanol in water than is the former clear film of crystalline Solef 21508. X-ray analysis of both films indicates that the drug is present in a non-crystalline form. Poor or very low solubility of the drug in the high HFP-containing copolymer results in slow permeation of the drug through the thin coating film. Permeability is the product of diffusion rate of the diffusing species (in this case the drug) through the film (the copolymer) and the solubility of the drug in the film.</p>
    <heading>Example 4</heading> <p>In Vitro Release Results of Rapamycin from Coating</p>
    <p>FIG. 1 is a plot of data for the 85.5/14.5 VDF/HFP polyfluoro copolymer, indicating fraction of drug released as a function of time, with no topcoat. FIG. 2 is a plot of data for the same polyfluoro copolymer over which a topcoat has been disposed, indicating that most effect on release rate is with a clear topcoat. As shown therein, TC150 refers to a device comprising 150 micrograms of topcoat, TC235 refers to 235 micrograms of topcoat, etc. The stents before top coating had an average of 750 micrograms of coating containing 30% rapamycin (based on drug/[drug+polymer]) FIG. 3 is a plot for the 60.6/39.4 VDF/HFP polyfluoro copolymer, indicating fraction of drug released as a function of time, showing significant control of release rate from the coating without the use of a topcoat. Release is controlled by loading of drug in the film.</p>
    <heading>Example 5</heading> <p>In Vivo Stent Release Kinetics of Rapamycin from Poly(VDF/HFP)</p>
    <p>Nine (9) New Zealand white rabbits (2.5-3.0 kg) on a normal diet were given aspirin 24 hours prior to surgery, again just prior to surgery and for the remainder of the study. At the time of surgery, animals were premedicated with Acepromazine (0.1-0.2 mg/kg) and anesthetized with a Ketamine/Xylazine mixture (40 mg/kg and 5 mg/kg, respectively). Animals were given a single intraprocedural dose of heparin (150 IU/kg, i.v.).</p>
    <p>Arteriectomy of the right common carotid artery was performed and 5 F catheter introducer (Cordis, Inc.) placed in the vessel and anchored with ligatures. Iodine contrast agent was injected to visualize the right common carotid artery, brachlocephalic trunk and aortic arch. A steerable guide wire (0.014 inch/180 cm, Cordis, Inc.) was inserted via the introducer and advanced sequentially into each iliac artery to a location where the artery possesses a diameter closest to 2 mm using the angiographic mapping done previously. Two stents coated with a film made from poly(VDF/HFP):(60.6/39.4), with about 30% rapamycin(based on drug/[drug+polymer]) were deployed in each animal where feasible, one in each iliac artery, using 3.0 mm balloon and inflation to 8-10 ATM for 30 seconds followed after a 1 minute interval by a second inflation to 8-10 ATM for 30 seconds. Follow-up angiographs visualizing both iliac arteries are obtained to confirm correct deployment position of the stent.</p>
    <p>At the end of procedure, the carotid artery was ligated and the skin is closed with 3/0 vicryl suture using a one layered interrupted closure. Animals were given butoropanol (0.4 mg/kg, s.c.) and gentamycin (4 mg/kg, i.m.). Following recovery, the animals were returned to their cages and allowed free access to food and water.</p>
    <p>Due to early deaths and surgical difficulties, 2 animals were not used in this analysis. Stented vessels were removed from the remaining 7 animals at the following time points: 1 vessel (1 animal) at 10 min post implant; 6 vessels (3 animals) between 45 min and 2 h post-implant (average, 1.2 hours); 2 vessels (2 animals) at 3 d post implant; and 2 vessels (1 animal) at 7 d post-implant. In one animal at 2 hours, the stent was retrieved from the aorta rather than the iliac artery. Upon removal, arteries were carefully trimmed at both the proximal and distal ends of the stent. Vessels were then carefully dissected free of the stent, flushed to remove any residual blood, and both stent and vessel frozen immediately, wrapped separately in foil, labeled and kept frozen at −80° C. When all samples had been collected, vessels and stents were frozen, transported and subsequently analyzed for rapamycin in tissue. Results are shown in FIG. <b>4</b>.</p>
    <heading>Example 6</heading> <p>Purifying the Polymer</p>
    <p>The Fluorel FC-2261Q copolymer was dissolved in MEK at about 10 weight percent and was washed in a 50/50 mixture of ethanol/water. The (ethanol/water): MEK solution ratio=about 14:1. The polymer precipitated out and was separated from the solvent phase by centrifugation. The polymer again was dissolved in MEK and the washing procedure repeated. The polymer was dried after each washing step at 60° C. in a vacuum oven (&lt;200 mtorr) over night.</p>
    <heading>Example 7</heading> <heading>In Vivo Testing of Coated Stents in Porcine Coronary Arteries</heading> <p>CrossFlex® stents (available from Cordis, a Johnson &amp; Johnson Company) were coated with the “as received” Fluorel FC-2261Q PVDF copolymer and with the purified polyfluoro copolymer of example 6, using the dip and wipe approach. The coated stents were sterilized using ethylene oxide and a standard cycle. The coated stents and bare metal stents (controls) were implanted in porcine coronary arteries, where they remained for 28 days.</p>
    <p>Angiography was performed on the pigs at implantation and at 28 days. Angiography indicated that the control uncoated stent exhibited about 21 percent restenosis. The polyfluoro copolymer “as received” exhibited about 26% restenosis (equivalent to the control) and the washed copolymer exhibited about 12.5% restenosis.</p>
    <p>Histology results reported neointimal area at 28 days to be 2.89±0.2, 3.57±0.4 and 2.75±0.3, respectively, for the bare metal control, the unpurified copolymer and the purified copolymer.</p>
    <heading>Example 8</heading> <p>Utilizing the following high pressure, free-radical batch emulsion polymerization technique, a series of semi-crystalline, poly(VDF/HFP) copolymer elastomers was prepared.</p>
    <p>The VDF and HFP monomers were premixed under pressure in a pressure vessel. HPLC-grade water, surfactant and initiator were mixed outside of a 2 liter Zipperclave® reactor (Autoclave Engineers, Erie, Pa.) and then charged to the reactor, which then was sealed. The premixed monomers then were transferred under nitrogen pressure to the reactor. While stirring, the reactor was raised to the desired temperature and held for a predetermined period of time. The reactor then was cooled and residual monomer vented. The resultant polymer latex was removed from the reactor and coagulated or crashed by adding dilute hydrochloric acid, followed by aqueous sodium chloride. The resulting polymer was washed extensively with water and dried.</p>
    <p>The polyfluoro copolymers then were compared with respect to kinetic coefficient of friction of a film prepared therefrom to the kinetic coefficient of friction of a film prepared from a commercial amorphous polyfluoro copolymer comprising 59.5 weight percent VDF copolymerized with 40.5 weight percent HFP utilizing the following procedure.</p>
    <p>A 57.2 mm wide by 140.0 mm long polymer film was cast on a 101.6 mm wide by 203.2 mm long aluminum panel (Q-panel, anodized finish, A-48). A silicone rubber gasket was placed on the aluminum panel and clamped using binder clips. The mold was leveled in a fume hood using a bubble level. Approximate 5.0 g of 10.0% polymer solution in methyl ethyl ketone was poured into the mold slowly. The film was dried at room temperature for 3 days followed by 3 hours at 23° C. and 50% R.H. prior to testing.</p>
    <p>The kinetic coefficient of friction of the polymer film was measured in accordance with the method described in ASTM D 1894-00, “Static and Kinetic Coefficients of Friction of Plastic Film and Sheeting”, Method C. A 46.5 g Teflon block, 25.4 mm wide by 41.3 mm long by 19.1 mm thick, with an eye screw fastened in one end was used as a sled. The surface of the sled that contacted to the film was polished using 500-grit sandpaper. The Teflon sled was attached to a flexible beaded chain and pulled using an Instron tensile tester at a rate of 150 mm/min., at 23° C. and 50% R.H. Five measurements was made on each film sample. The thickness of the film was measured using a digital thickness gauge. The kinetic coefficient test results are given in Table I. The maximum kinetic coefficient of friction of five measurements of each film were averaged and reported.</p>
    <p>The Differential Scanning Calorimetry (DSC) data were obtained on the following polymers using vacuum dried films in a TA Instruments Model 2920 Modulated DSC in standard (non-modulated) DSC mode. The samples were quenched to −80° C. and heated at 10° C./min to 275° C. in nitrogen. The data are reported as ΔH (J/g) for endothermic, melting events above glass transition temperature (Tg).</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="1"> <colspec colname="1" colwidth="217pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td namest="1" nameend="1" rowsep="1" class="description-td" colspan="1">TABLE I</td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td" colspan="1"> </td>
              </tr> <tr class="description-tr"> <td class="description-td">Kinetic Coefficient of Polymer Film</td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="5"> <colspec colname="offset" colwidth="14pt" align="left"> </colspec> <colspec colname="1" colwidth="42pt" align="center"> </colspec> <colspec colname="2" colwidth="56pt" align="center"> </colspec> <colspec colname="3" colwidth="42pt" align="center"> </colspec> <colspec colname="4" colwidth="63pt" align="center"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sample I.D.</td>
                <td class="description-td">Film</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Wt/wt</td>
                <td class="description-td">Thickness</td>
                <td class="description-td">Max. Kinetic</td>
                <td class="description-td">DSC</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">VDF/HFP</td>
                <td class="description-td">(μm)</td>
                <td class="description-td">Coefficient</td>
                <td class="description-td">ΔH (J/g)</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="offset" nameend="4" align="center" rowsep="1" class="description-td" colspan="5"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Commercial</td>
                <td class="description-td">22.9</td>
                <td class="description-td">2.65</td>
                <td class="description-td">None</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">59.5/40.5</td>
                <td class="description-td"> </td>
                <td class="description-td">σ = 0.17</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Polymer 8a</td>
                <td class="description-td">38.6</td>
                <td class="description-td">1.71</td>
                <td class="description-td">16.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">55.1/44.9</td>
                <td class="description-td"> </td>
                <td class="description-td">σ = 0.09</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Polymer 8b</td>
                <td class="description-td">27.5</td>
                <td class="description-td">0.27</td>
                <td class="description-td">15</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">56.8/43.2</td>
                <td class="description-td"> </td>
                <td class="description-td">σ = 0.03</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Polymer 8c</td>
                <td class="description-td">25.4</td>
                <td class="description-td">0.35</td>
                <td class="description-td">19.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">68.3/31.7</td>
                <td class="description-td"> </td>
                <td class="description-td">σ = 0.07</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Polymer 8d</td>
                <td class="description-td">21.1</td>
                <td class="description-td">2.12</td>
                <td class="description-td">4.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">59.9/40.1</td>
                <td class="description-td"> </td>
                <td class="description-td">σ = 0.04</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="offset" nameend="4" align="center" rowsep="1" class="description-td" colspan="5"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3051677">US3051677</a></td><td class="patent-data-table-td patent-date-value">Apr 29, 1957</td><td class="patent-data-table-td patent-date-value">Aug 28, 1962</td><td class="patent-data-table-td ">Du Pont</td><td class="patent-data-table-td ">Copolymer elastomer of vinylidenefluoride and hexafluoropropene</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3779805">US3779805</a></td><td class="patent-data-table-td patent-date-value">May 19, 1971</td><td class="patent-data-table-td patent-date-value">Dec 18, 1973</td><td class="patent-data-table-td ">Bell Telephone Labor Inc</td><td class="patent-data-table-td ">Method of making waveguide mode filter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4413359">US4413359</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 26, 1982</td><td class="patent-data-table-td patent-date-value">Nov 8, 1983</td><td class="patent-data-table-td ">Koken Co., Ltd.</td><td class="patent-data-table-td ">Impermeable laminate membrane</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4423183">US4423183</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 25, 1981</td><td class="patent-data-table-td patent-date-value">Dec 27, 1983</td><td class="patent-data-table-td ">David Hudson, Inc.</td><td class="patent-data-table-td ">Free of metal oxides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4733665">US4733665</a></td><td class="patent-data-table-td patent-date-value">Nov 7, 1985</td><td class="patent-data-table-td patent-date-value">Mar 29, 1988</td><td class="patent-data-table-td ">Expandable Grafts Partnership</td><td class="patent-data-table-td ">Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4749585">US4749585</a></td><td class="patent-data-table-td patent-date-value">Apr 11, 1986</td><td class="patent-data-table-td patent-date-value">Jun 7, 1988</td><td class="patent-data-table-td ">University Of Medicine And Dentistry Of New Jersey</td><td class="patent-data-table-td ">Coating of ionic surfactant and drug encapsulated with phospholipid vesicles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4800882">US4800882</a></td><td class="patent-data-table-td patent-date-value">Mar 13, 1987</td><td class="patent-data-table-td patent-date-value">Jan 31, 1989</td><td class="patent-data-table-td ">Cook Incorporated</td><td class="patent-data-table-td ">Endovascular stent and delivery system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4871357">US4871357</a></td><td class="patent-data-table-td patent-date-value">Sep 14, 1987</td><td class="patent-data-table-td patent-date-value">Oct 3, 1989</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Ionic heparin coating</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4876109">US4876109</a></td><td class="patent-data-table-td patent-date-value">Nov 18, 1988</td><td class="patent-data-table-td patent-date-value">Oct 24, 1989</td><td class="patent-data-table-td ">Cardiac Pacemakers, Inc.</td><td class="patent-data-table-td ">Dip coating with biocompatible, antipyretic material</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4886062">US4886062</a></td><td class="patent-data-table-td patent-date-value">Oct 19, 1987</td><td class="patent-data-table-td patent-date-value">Dec 12, 1989</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Intravascular radially expandable stent and method of implant</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5047020">US5047020</a></td><td class="patent-data-table-td patent-date-value">Jul 31, 1989</td><td class="patent-data-table-td patent-date-value">Sep 10, 1991</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Frialkylbenzyl ammonium salt complex; medical equipment; anticoagulants</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5053048">US5053048</a></td><td class="patent-data-table-td patent-date-value">Nov 8, 1990</td><td class="patent-data-table-td patent-date-value">Oct 1, 1991</td><td class="patent-data-table-td ">Cordis Corporation</td><td class="patent-data-table-td ">Thromboresistant coating</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5176972">US5176972</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 11, 1991</td><td class="patent-data-table-td patent-date-value">Jan 5, 1993</td><td class="patent-data-table-td ">Polaroid Corporation</td><td class="patent-data-table-td ">Image enhancement layer is a fluoropolymer, diffusion transfer films</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5185408">US5185408</a></td><td class="patent-data-table-td patent-date-value">Nov 18, 1991</td><td class="patent-data-table-td patent-date-value">Feb 9, 1993</td><td class="patent-data-table-td ">Allied-Signal Inc.</td><td class="patent-data-table-td ">Prosthetic tubular graft for surgical implantation in animals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5336518">US5336518</a></td><td class="patent-data-table-td patent-date-value">Dec 11, 1992</td><td class="patent-data-table-td patent-date-value">Aug 9, 1994</td><td class="patent-data-table-td ">Cordis Corporation</td><td class="patent-data-table-td ">Treatment of metallic surfaces using radiofrequency plasma deposition and chemical attachment of bioactive agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5342348">US5342348</a></td><td class="patent-data-table-td patent-date-value">Dec 4, 1992</td><td class="patent-data-table-td patent-date-value">Aug 30, 1994</td><td class="patent-data-table-td ">Kaplan Aaron V</td><td class="patent-data-table-td ">Method and device for treating and enlarging body lumens</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5368566">US5368566</a></td><td class="patent-data-table-td patent-date-value">Apr 29, 1992</td><td class="patent-data-table-td patent-date-value">Nov 29, 1994</td><td class="patent-data-table-td ">Cardiovascular Dynamics, Inc.</td><td class="patent-data-table-td ">Delivery and temporary stent catheter having a reinforced perfusion lumen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5380299">US5380299</a></td><td class="patent-data-table-td patent-date-value">Aug 30, 1993</td><td class="patent-data-table-td patent-date-value">Jan 10, 1995</td><td class="patent-data-table-td ">Med Institute, Inc.</td><td class="patent-data-table-td ">Thrombolytic treated intravascular medical device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5383853">US5383853</a></td><td class="patent-data-table-td patent-date-value">Nov 12, 1992</td><td class="patent-data-table-td patent-date-value">Jan 24, 1995</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Rapid exchange catheter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5383928">US5383928</a></td><td class="patent-data-table-td patent-date-value">Aug 19, 1993</td><td class="patent-data-table-td patent-date-value">Jan 24, 1995</td><td class="patent-data-table-td ">Emory University</td><td class="patent-data-table-td ">Cardiovascular disorders</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5403341">US5403341</a></td><td class="patent-data-table-td patent-date-value">Jan 24, 1994</td><td class="patent-data-table-td patent-date-value">Apr 4, 1995</td><td class="patent-data-table-td ">Solar; Ronald J.</td><td class="patent-data-table-td ">Parallel flow endovascular stent and deployment apparatus therefore</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5417969">US5417969</a></td><td class="patent-data-table-td patent-date-value">Nov 18, 1993</td><td class="patent-data-table-td patent-date-value">May 23, 1995</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Heparin neutralized with amine compounds over films of polyvinyl chloride for medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5443458">US5443458</a></td><td class="patent-data-table-td patent-date-value">Dec 3, 1993</td><td class="patent-data-table-td patent-date-value">Aug 22, 1995</td><td class="patent-data-table-td ">Advanced Cardiovascular Systems, Inc.</td><td class="patent-data-table-td ">Multilayered biodegradable stent and method of manufacture</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5447724">US5447724</a></td><td class="patent-data-table-td patent-date-value">Nov 15, 1993</td><td class="patent-data-table-td patent-date-value">Sep 5, 1995</td><td class="patent-data-table-td ">Harbor Medical Devices, Inc.</td><td class="patent-data-table-td ">Has tissue exposed portion to release agent inhibiting adverse reaction to its presence; polymeric surface layer over reservoir; blood oxygenator</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5464650">US5464650</a></td><td class="patent-data-table-td patent-date-value">Apr 26, 1993</td><td class="patent-data-table-td patent-date-value">Nov 7, 1995</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Intravascular stent and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5545208">US5545208</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 1993</td><td class="patent-data-table-td patent-date-value">Aug 13, 1996</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Intralumenal drug eluting prosthesis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5569463">US5569463</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Oct 29, 1996</td><td class="patent-data-table-td ">Harbor Medical Devices, Inc.</td><td class="patent-data-table-td ">Medical device polymer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5575818">US5575818</a></td><td class="patent-data-table-td patent-date-value">Feb 14, 1995</td><td class="patent-data-table-td patent-date-value">Nov 19, 1996</td><td class="patent-data-table-td ">Corvita Corporation</td><td class="patent-data-table-td ">Endovascular stent with locking ring</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5591224">US5591224</a></td><td class="patent-data-table-td patent-date-value">Sep 15, 1994</td><td class="patent-data-table-td patent-date-value">Jan 7, 1997</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Bioelastomeric stent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5604283">US5604283</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 26, 1992</td><td class="patent-data-table-td patent-date-value">Feb 18, 1997</td><td class="patent-data-table-td ">Daikin Industries, Ltd.</td><td class="patent-data-table-td ">Liquid mixture with coupling agent, amine or polyol crosslinking agent and carboxylic acid, pot life</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5616608">US5616608</a></td><td class="patent-data-table-td patent-date-value">Apr 18, 1996</td><td class="patent-data-table-td patent-date-value">Apr 1, 1997</td><td class="patent-data-table-td ">The United States Of America As Represented By The Department Of Health And Human Services</td><td class="patent-data-table-td ">Method of treating atherosclerosis or restenosis using microtubule stabilizing agent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5632771">US5632771</a></td><td class="patent-data-table-td patent-date-value">Jan 25, 1995</td><td class="patent-data-table-td patent-date-value">May 27, 1997</td><td class="patent-data-table-td ">Cook Incorporated</td><td class="patent-data-table-td ">Flexible stent having a pattern formed from a sheet of material</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5632776">US5632776</a></td><td class="patent-data-table-td patent-date-value">Aug 15, 1994</td><td class="patent-data-table-td patent-date-value">May 27, 1997</td><td class="patent-data-table-td ">Toray Industries, Inc.</td><td class="patent-data-table-td ">Implantation materials</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5632840">US5632840</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 1995</td><td class="patent-data-table-td patent-date-value">May 27, 1997</td><td class="patent-data-table-td ">Advanced Cardiovascular System, Inc.</td><td class="patent-data-table-td ">Method of making metal reinforced polymer stent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5635201">US5635201</a></td><td class="patent-data-table-td patent-date-value">Mar 30, 1993</td><td class="patent-data-table-td patent-date-value">Jun 3, 1997</td><td class="patent-data-table-td ">Molnlycke Ab</td><td class="patent-data-table-td ">Method and an arrangement for manufacturing wound dressings, and a wound dressing manufactured in accordance with the method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5665728">US5665728</a></td><td class="patent-data-table-td patent-date-value">May 26, 1995</td><td class="patent-data-table-td patent-date-value">Sep 9, 1997</td><td class="patent-data-table-td ">American Home Products Corporation</td><td class="patent-data-table-td ">Administering rapamycin</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5679400">US5679400</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Oct 21, 1997</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Intravascular stent and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5684061">US5684061</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 26, 1996</td><td class="patent-data-table-td patent-date-value">Nov 4, 1997</td><td class="patent-data-table-td ">Kureha Chemical Industry Co., Ltd.</td><td class="patent-data-table-td ">Bone inducing material</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5691311">US5691311</a></td><td class="patent-data-table-td patent-date-value">May 11, 1995</td><td class="patent-data-table-td patent-date-value">Nov 25, 1997</td><td class="patent-data-table-td ">Biogen, Inc.</td><td class="patent-data-table-td ">Methods for coating invasive devices with inhibitors of thrombin</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5697967">US5697967</a></td><td class="patent-data-table-td patent-date-value">Apr 27, 1995</td><td class="patent-data-table-td patent-date-value">Dec 16, 1997</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Drug eluting stent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5713949">US5713949</a></td><td class="patent-data-table-td patent-date-value">Aug 6, 1996</td><td class="patent-data-table-td patent-date-value">Feb 3, 1998</td><td class="patent-data-table-td ">Jayaraman; Swaminathan</td><td class="patent-data-table-td ">Microporous covered stents and method of coating</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5716981">US5716981</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Feb 10, 1998</td><td class="patent-data-table-td ">Angiogenesis Technologies, Inc.</td><td class="patent-data-table-td ">A stent coated with paclitaxel, a taxan derivative and a polymeric carrier; medical equipment for deblocking</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5759205">US5759205</a></td><td class="patent-data-table-td patent-date-value">Jan 20, 1995</td><td class="patent-data-table-td patent-date-value">Jun 2, 1998</td><td class="patent-data-table-td ">Brown University Research Foundation</td><td class="patent-data-table-td ">Negatively charged polymeric electret implant</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5776184">US5776184</a></td><td class="patent-data-table-td patent-date-value">Oct 9, 1996</td><td class="patent-data-table-td patent-date-value">Jul 7, 1998</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Intravasoular stent and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5824048">US5824048</a></td><td class="patent-data-table-td patent-date-value">Oct 9, 1996</td><td class="patent-data-table-td patent-date-value">Oct 20, 1998</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Method for delivering a therapeutic substance to a body lumen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5824049">US5824049</a></td><td class="patent-data-table-td patent-date-value">Oct 31, 1996</td><td class="patent-data-table-td patent-date-value">Oct 20, 1998</td><td class="patent-data-table-td ">Med Institute, Inc.</td><td class="patent-data-table-td ">Coated stent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5827587">US5827587</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 12, 1997</td><td class="patent-data-table-td patent-date-value">Oct 27, 1998</td><td class="patent-data-table-td ">Minnesota Mining And Manufacturing Company</td><td class="patent-data-table-td ">Multi-layer compositions having a fluoropolymer layer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5865814">US5865814</a></td><td class="patent-data-table-td patent-date-value">Aug 6, 1997</td><td class="patent-data-table-td patent-date-value">Feb 2, 1999</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Blood contacting medical device and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5873904">US5873904</a></td><td class="patent-data-table-td patent-date-value">Feb 24, 1997</td><td class="patent-data-table-td patent-date-value">Feb 23, 1999</td><td class="patent-data-table-td ">Cook Incorporated</td><td class="patent-data-table-td ">Silver implantable medical device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5879697">US5879697</a></td><td class="patent-data-table-td patent-date-value">Apr 30, 1997</td><td class="patent-data-table-td patent-date-value">Mar 9, 1999</td><td class="patent-data-table-td ">Schneider Usa Inc</td><td class="patent-data-table-td ">Outer layer comprises ionic surfactant complexed to biologically active material and reservoir layer comprises a polymer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5897911">US5897911</a></td><td class="patent-data-table-td patent-date-value">Aug 11, 1997</td><td class="patent-data-table-td patent-date-value">Apr 27, 1999</td><td class="patent-data-table-td ">Advanced Cardiovascular Systems, Inc.</td><td class="patent-data-table-td ">Controlled thickness coating of a metal stent with polymer by fitting a mandrel into the stent, flowing polymer, solidifying or curing polymer and removing the mandrel</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5922393">US5922393</a></td><td class="patent-data-table-td patent-date-value">Jul 6, 1998</td><td class="patent-data-table-td patent-date-value">Jul 13, 1999</td><td class="patent-data-table-td ">Jayaraman; Swaminathan</td><td class="patent-data-table-td ">Unexpanded stent is placed over a mandrel and inserted into an elongated recess eccentrically located within a larger mandrel; then coating, when mandrels are removed the stent has an enlarged coating attached to one elongated location</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5932299">US5932299</a></td><td class="patent-data-table-td patent-date-value">Apr 22, 1997</td><td class="patent-data-table-td patent-date-value">Aug 3, 1999</td><td class="patent-data-table-td ">Katoot; Mohammad W.</td><td class="patent-data-table-td ">Employing infrared radiation, microwave radiation or high voltage polymerization for modifying the surfaces of materials to impart desired characteristics thereto.</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6153252">US6153252</a></td><td class="patent-data-table-td patent-date-value">Apr 19, 1999</td><td class="patent-data-table-td patent-date-value">Nov 28, 2000</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Process for coating stents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/DE19723723A1?cl=en">DE19723723A1</a></td><td class="patent-data-table-td patent-date-value">May 30, 1997</td><td class="patent-data-table-td patent-date-value">Dec 3, 1998</td><td class="patent-data-table-td ">Fraunhofer Ges Forschung</td><td class="patent-data-table-td ">Piezoelectric fluoro copolymer coatings on prostheses, implants or electrodes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0568310A1?cl=en">EP0568310A1</a></td><td class="patent-data-table-td patent-date-value">Apr 27, 1993</td><td class="patent-data-table-td patent-date-value">Nov 3, 1993</td><td class="patent-data-table-td ">American Home Products Corporation</td><td class="patent-data-table-td ">Composition comprising heparin and rapamycin</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0633032A1?cl=en">EP0633032A1</a></td><td class="patent-data-table-td patent-date-value">Jun 24, 1994</td><td class="patent-data-table-td patent-date-value">Jan 11, 1995</td><td class="patent-data-table-td ">Sumitomo Electric Industries, Ltd.</td><td class="patent-data-table-td ">Antibacterial vascular prosthesis and surgical suture</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0747069A2?cl=en">EP0747069A2</a></td><td class="patent-data-table-td patent-date-value">Jun 4, 1996</td><td class="patent-data-table-td patent-date-value">Dec 11, 1996</td><td class="patent-data-table-td ">Cook Incorporated</td><td class="patent-data-table-td ">Implantable medical device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0815803A1?cl=en">EP0815803A1</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 1997</td><td class="patent-data-table-td patent-date-value">Jan 7, 1998</td><td class="patent-data-table-td ">Cordis Europa N.V.</td><td class="patent-data-table-td ">Catheter with temporary vena cava filter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0950386A2?cl=en">EP0950386A2</a></td><td class="patent-data-table-td patent-date-value">Apr 15, 1999</td><td class="patent-data-table-td patent-date-value">Oct 20, 1999</td><td class="patent-data-table-td ">Cordis Corporation</td><td class="patent-data-table-td ">Stent with local rapamycin delivery</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0968688A1?cl=en">EP0968688A1</a></td><td class="patent-data-table-td patent-date-value">Jul 1, 1999</td><td class="patent-data-table-td patent-date-value">Jan 5, 2000</td><td class="patent-data-table-td ">Cordis Europa N.V.</td><td class="patent-data-table-td ">Improved vascular filter for controlled release</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1192957A2?cl=en">EP1192957A2</a></td><td class="patent-data-table-td patent-date-value">Sep 28, 2001</td><td class="patent-data-table-td patent-date-value">Apr 3, 2002</td><td class="patent-data-table-td ">Ethicon Inc.</td><td class="patent-data-table-td ">Coating for medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1998008463A1?cl=en">WO1998008463A1</a></td><td class="patent-data-table-td patent-date-value">Aug 26, 1997</td><td class="patent-data-table-td patent-date-value">Mar 5, 1998</td><td class="patent-data-table-td ">Helix Med Corp</td><td class="patent-data-table-td ">Medical devices having microbial resistant material properties</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1998036784A1?cl=en">WO1998036784A1</a></td><td class="patent-data-table-td patent-date-value">Feb 20, 1998</td><td class="patent-data-table-td patent-date-value">Aug 27, 1998</td><td class="patent-data-table-td ">Cook Inc</td><td class="patent-data-table-td ">Coated implantable medical device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2000027455A1?cl=en">WO2000027455A1</a></td><td class="patent-data-table-td patent-date-value">Nov 3, 1999</td><td class="patent-data-table-td patent-date-value">May 18, 2000</td><td class="patent-data-table-td ">Salter Labs</td><td class="patent-data-table-td ">Nebulizer mouthpiece and accessories</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2000038754A1?cl=en">WO2000038754A1</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 1999</td><td class="patent-data-table-td patent-date-value">Jul 6, 2000</td><td class="patent-data-table-td ">Atrium Medical Corp</td><td class="patent-data-table-td ">Self-expanding prosthesis with biocompatible coating</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2001087342A2?cl=en">WO2001087342A2</a></td><td class="patent-data-table-td patent-date-value">May 14, 2001</td><td class="patent-data-table-td patent-date-value">Nov 22, 2001</td><td class="patent-data-table-td ">Cordis Corp</td><td class="patent-data-table-td ">Delivery devices for treatment of vascular disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2001087376A1?cl=en">WO2001087376A1</a></td><td class="patent-data-table-td patent-date-value">May 14, 2001</td><td class="patent-data-table-td patent-date-value">Nov 22, 2001</td><td class="patent-data-table-td ">Cordis Corp</td><td class="patent-data-table-td ">Drug/drug delivery systems for the prevention and treatment of vascular disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2002026139A1?cl=en">WO2002026139A1</a></td><td class="patent-data-table-td patent-date-value">Sep 28, 2001</td><td class="patent-data-table-td patent-date-value">Apr 4, 2002</td><td class="patent-data-table-td ">Cordis Corp</td><td class="patent-data-table-td ">Coated medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2002026281A1?cl=en">WO2002026281A1</a></td><td class="patent-data-table-td patent-date-value">Sep 28, 2001</td><td class="patent-data-table-td patent-date-value">Apr 4, 2002</td><td class="patent-data-table-td ">Cordis Corp</td><td class="patent-data-table-td ">Coated medical devices</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Derwent Acc. No. 1999-025723, abstract of DE 19723723 A1, Dec. 3, 1998.*</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Encyclopedia of Polymer Science and Engineering, vol. 7: fluorocarbon Elastomers, p. 257-267, Mar. 1989.*</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">European Search Report EP03254747 dated Dec. 3, 2003.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">I. Verweire, E. Schact, B. P. Qiang, K. Wang, I. De Scheerder, "<a href='http://scholar.google.com/scholar?q="Evaluation+of+Fluorinated+Polymers+As+Coronary+Stent+Coating%2C"'>Evaluation of Fluorinated Polymers As Coronary Stent Coating,</a>" Journal of Materials Science: Materials in Medicine 11. Apr. 2000.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">PCT International Search Report, PCT/US01/30389, Mar. 11, 2002.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7309361">US7309361</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 2, 2003</td><td class="patent-data-table-td patent-date-value">Dec 18, 2007</td><td class="patent-data-table-td ">Wasielewski Ray C</td><td class="patent-data-table-td ">Biologic modular tibial and femoral component augments for use with total knee arthroplasty</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7591844">US7591844</a></td><td class="patent-data-table-td patent-date-value">Nov 16, 2007</td><td class="patent-data-table-td patent-date-value">Sep 22, 2009</td><td class="patent-data-table-td ">Cordis Corporation</td><td class="patent-data-table-td ">Medical devices, drug coatings and methods for maintaining the drug coatings thereon</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7666462">US7666462</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 7, 2006</td><td class="patent-data-table-td patent-date-value">Feb 23, 2010</td><td class="patent-data-table-td ">Exogenesis Corporation</td><td class="patent-data-table-td ">Method of controlling a drug release rate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7682387">US7682387</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 5, 2003</td><td class="patent-data-table-td patent-date-value">Mar 23, 2010</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method for treating restenosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7727275">US7727275</a></td><td class="patent-data-table-td patent-date-value">Sep 20, 2004</td><td class="patent-data-table-td patent-date-value">Jun 1, 2010</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method of forming the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7731685">US7731685</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 23, 2005</td><td class="patent-data-table-td patent-date-value">Jun 8, 2010</td><td class="patent-data-table-td ">Cook Incorporated</td><td class="patent-data-table-td ">Coated medical device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7770536">US7770536</a></td><td class="patent-data-table-td patent-date-value">Apr 15, 2008</td><td class="patent-data-table-td patent-date-value">Aug 10, 2010</td><td class="patent-data-table-td ">Advanced Cardiovascular Systems, Inc.</td><td class="patent-data-table-td ">Coating abluminal surfaces of stents and other implantable medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7901451">US7901451</a></td><td class="patent-data-table-td patent-date-value">Sep 22, 2005</td><td class="patent-data-table-td patent-date-value">Mar 8, 2011</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method for treating restenosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7923055">US7923055</a></td><td class="patent-data-table-td patent-date-value">Oct 17, 2006</td><td class="patent-data-table-td patent-date-value">Apr 12, 2011</td><td class="patent-data-table-td ">Exogenesis Corporation</td><td class="patent-data-table-td ">Method of manufacturing a drug delivery system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8052658">US8052658</a></td><td class="patent-data-table-td patent-date-value">Oct 5, 2006</td><td class="patent-data-table-td patent-date-value">Nov 8, 2011</td><td class="patent-data-table-td ">Bard Peripheral Vascular, Inc.</td><td class="patent-data-table-td ">Drug-eluting tissue marker</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8067055">US8067055</a></td><td class="patent-data-table-td patent-date-value">Mar 23, 2007</td><td class="patent-data-table-td patent-date-value">Nov 29, 2011</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method of use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8084076">US8084076</a></td><td class="patent-data-table-td patent-date-value">Feb 7, 2008</td><td class="patent-data-table-td patent-date-value">Dec 27, 2011</td><td class="patent-data-table-td ">Sorin Biomedica Cardio S.R.L.</td><td class="patent-data-table-td ">Process for producing stents and corresponding stents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8117984">US8117984</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 2010</td><td class="patent-data-table-td patent-date-value">Feb 21, 2012</td><td class="patent-data-table-td ">Advanced Cardiovascular Systems, Inc.</td><td class="patent-data-table-td ">Coating abluminal surfaces of stents and other implantable medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8187662">US8187662</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 2009</td><td class="patent-data-table-td patent-date-value">May 29, 2012</td><td class="patent-data-table-td ">Exogenesis Corporation</td><td class="patent-data-table-td ">Method of controlling a drug release rate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8202654">US8202654</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2009</td><td class="patent-data-table-td patent-date-value">Jun 19, 2012</td><td class="patent-data-table-td ">Boston Scientific Scimed, Inc.</td><td class="patent-data-table-td ">Medical devices having fluorocarbon polymer coatings</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8216600">US8216600</a></td><td class="patent-data-table-td patent-date-value">Nov 14, 2007</td><td class="patent-data-table-td patent-date-value">Jul 10, 2012</td><td class="patent-data-table-td ">Cordis Corporation</td><td class="patent-data-table-td ">Polymeric materials for medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8252046">US8252046</a></td><td class="patent-data-table-td patent-date-value">Dec 15, 2009</td><td class="patent-data-table-td patent-date-value">Aug 28, 2012</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method for treating restenosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8252047">US8252047</a></td><td class="patent-data-table-td patent-date-value">Feb 8, 2011</td><td class="patent-data-table-td patent-date-value">Aug 28, 2012</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method for treating restenosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8252418">US8252418</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2011</td><td class="patent-data-table-td patent-date-value">Aug 28, 2012</td><td class="patent-data-table-td ">Exogenesis Corporation</td><td class="patent-data-table-td ">Drug delivery system and method of manufacturing thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8308795">US8308795</a></td><td class="patent-data-table-td patent-date-value">Jan 29, 2010</td><td class="patent-data-table-td patent-date-value">Nov 13, 2012</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method of forming the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8312838">US8312838</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 2010</td><td class="patent-data-table-td patent-date-value">Nov 20, 2012</td><td class="patent-data-table-td ">Advanced Cardiovascular Systems Inc.</td><td class="patent-data-table-td ">Coating abluminal surfaces of stents and other implantable medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8323676">US8323676</a></td><td class="patent-data-table-td patent-date-value">Jun 30, 2008</td><td class="patent-data-table-td patent-date-value">Dec 4, 2012</td><td class="patent-data-table-td ">Abbott Cardiovascular Systems Inc.</td><td class="patent-data-table-td ">Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8387553">US8387553</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 2010</td><td class="patent-data-table-td patent-date-value">Mar 5, 2013</td><td class="patent-data-table-td ">Advanced Cardiovascular Systems Inc.</td><td class="patent-data-table-td ">Coating abluminal surfaces of stents and other implantable medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8545550">US8545550</a></td><td class="patent-data-table-td patent-date-value">Jul 24, 2012</td><td class="patent-data-table-td patent-date-value">Oct 1, 2013</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method for treating restenosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8586125">US8586125</a></td><td class="patent-data-table-td patent-date-value">Sep 16, 2010</td><td class="patent-data-table-td patent-date-value">Nov 19, 2013</td><td class="patent-data-table-td ">Advanced Cardiovascular Systems, Inc.</td><td class="patent-data-table-td ">Thermal treatment of an implantable medical device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8679519">US8679519</a></td><td class="patent-data-table-td patent-date-value">Oct 23, 2007</td><td class="patent-data-table-td patent-date-value">Mar 25, 2014</td><td class="patent-data-table-td ">Abbott Cardiovascular Systems Inc.</td><td class="patent-data-table-td ">Coating designs for the tailored release of dual drugs from polymeric coatings</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8715341">US8715341</a></td><td class="patent-data-table-td patent-date-value">Oct 9, 2012</td><td class="patent-data-table-td patent-date-value">May 6, 2014</td><td class="patent-data-table-td ">Biosensors International Group, Ltd.</td><td class="patent-data-table-td ">Drug-delivery endovascular stent and method of forming the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8765162">US8765162</a></td><td class="patent-data-table-td patent-date-value">Jun 30, 2008</td><td class="patent-data-table-td patent-date-value">Jul 1, 2014</td><td class="patent-data-table-td ">Abbott Cardiovascular Systems Inc.</td><td class="patent-data-table-td ">Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2067493A1?cl=en">EP2067493A1</a></td><td class="patent-data-table-td patent-date-value">Nov 13, 2008</td><td class="patent-data-table-td patent-date-value">Jun 10, 2009</td><td class="patent-data-table-td ">Cordis Corporation</td><td class="patent-data-table-td ">Polymeric materials for medical devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2007092894A2?cl=en">WO2007092894A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 7, 2007</td><td class="patent-data-table-td patent-date-value">Aug 16, 2007</td><td class="patent-data-table-td ">Exogenesis Corp</td><td class="patent-data-table-td ">Drug delivery system and method of manufacturing thereof</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc428/defs428.htm&usg=AFQjCNHweszibnXGL6TbGo0K-aDr8N_bfQ#C428S421000">428/421</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc623/defs623.htm&usg=AFQjCNEoAr8t6321S-dcUmO_Vn1Bftf5NA#C623S001420">623/1.42</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc623/defs623.htm&usg=AFQjCNEoAr8t6321S-dcUmO_Vn1Bftf5NA#C623S001430">623/1.43</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc604/defs604.htm&usg=AFQjCNHGbKWMrM4_7EhVgHqTGyq5436gEQ#C604S890100">604/890.1</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc623/defs623.htm&usg=AFQjCNEoAr8t6321S-dcUmO_Vn1Bftf5NA#C623S001440">623/1.44</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc623/defs623.htm&usg=AFQjCNEoAr8t6321S-dcUmO_Vn1Bftf5NA#C623S001490">623/1.49</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc604/defs604.htm&usg=AFQjCNHGbKWMrM4_7EhVgHqTGyq5436gEQ#C604S891100">604/891.1</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc604/defs604.htm&usg=AFQjCNHGbKWMrM4_7EhVgHqTGyq5436gEQ#C604S265000">604/265</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61F0002060000">A61F2/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0017040000">A61B17/04</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0031000000">A61L31/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0031160000">A61L31/16</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0017064000">A61B17/064</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0017140000">A61L17/14</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0017115000">A61B17/115</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0031100000">A61L31/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0017110000">A61B17/11</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61F0002000000">A61F2/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0017000000">A61B17/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0027340000">A61L27/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0017540000">A61B17/54</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0017060000">A61B17/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0029080000">A61L29/08</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0031020000">A61L31/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0033100000">A61L33/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0027000000">A61L27/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0045060000">A61K45/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031436000">A61K31/436</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0031180000">A61L31/18</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031727000">A61K31/727</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2002/3008">A61F2002/3008</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K45/06">A61K45/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/727">A61K31/727</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2/91">A61F2/91</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B17/115">A61B17/115</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L29/085">A61L29/085</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2310/00976">A61F2310/00976</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B17/0644">A61B17/0644</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B17/0469">A61B17/0469</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B17/11">A61B17/11</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2310/0097">A61F2310/0097</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2250/0067">A61F2250/0067</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2002/91533">A61F2002/91533</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B17/00491">A61B17/00491</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2/064">A61F2/064</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B2017/06028">A61B2017/06028</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L31/10">A61L31/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B17/54">A61B17/54</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L31/022">A61L31/022</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2250/0098">A61F2250/0098</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L31/18">A61L31/18</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L27/34">A61L27/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2/915">A61F2/915</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2002/91558">A61F2002/91558</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L17/145">A61L17/145</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=optmBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/436">A61K31/436</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61F2/91</span>, <span class="nested-value">A61F2/915</span>, <span class="nested-value">A61L29/08B</span>, <span class="nested-value">A61L27/34</span>, <span class="nested-value">A61L31/10</span>, <span class="nested-value">A61B17/11</span>, <span class="nested-value">A61B17/115</span>, <span class="nested-value">A61B17/064D</span>, <span class="nested-value">A61B17/54</span>, <span class="nested-value">A61L17/14C</span>, <span class="nested-value">A61K45/06</span>, <span class="nested-value">A61L31/02B</span>, <span class="nested-value">A61K31/436</span>, <span class="nested-value">A61K31/727</span>, <span class="nested-value">A61L31/18</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Sep 21, 2011</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 9, 2010</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20100823</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 13, 2010</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 1-3 AND 5 ARE CANCELLED. CLAIM 4 IS DETERMINED TO BE PATENTABLE AS AMENDED. NEW CLAIMS 6-9 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 17, 2009</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">CORDIS CORPORATION, FLORIDA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FALOTICO, ROBERT;REEL/FRAME:023247/0158</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20090624</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">WYETH, NEW JERSEY</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 13, 2007</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">WYETH, NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CORDIS CORPORATION;REEL/FRAME:020234/0460</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20071212</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">WYETH,NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CORDIS CORPORATION;US-ASSIGNMENT DATABASE UPDATED:20100316;REEL/FRAME:20234/460</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CORDIS CORPORATION;US-ASSIGNMENT DATABASE UPDATED:20100413;REEL/FRAME:20234/460</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 5, 2007</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">CORDIS CORPORATION, FLORIDA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ETHICON, INC.;REEL/FRAME:020201/0026</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20071201</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 26, 2007</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 11, 2002</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ETHICON, INC., NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LLANOS, GERARD H.;NARAYANAN, PALLASSANA;ROLLER, MARK B.;AND OTHERS;REEL/FRAME:012486/0244</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20011119</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ETHICON, INC. U.S. ROUTE 22SOMERVILLE, NEW JERSEY,</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LLANOS, GERARD H. /AR;REEL/FRAME:012486/0244</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U04SLU3xQ_7r6JS2CmbLzXZN8Ebyw\u0026id=optmBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U1UnisOw4doRQtVbklQfJnuUWlAjA\u0026id=optmBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U3YpnnDVY4A2So10-Ud7zmS5QV_eA","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Implant_with_coating_of_copolymer_of_vin.pdf?id=optmBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3TikuZZWETGaoxRKB4LQsZUq9tbQ"},"sample_url":"http://www.google.com/patents/reader?id=optmBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>